Immune-related adverse events after a single dose of pembrolizumab

被引：1
|
作者：
Vos, Hanne [1 ]
Lambein, Kathleen [1 ]
Wildiers, Hans [2 ,3 ]
Punie, Kevin [2 ,3 ]
Smeets, Ann [1 ,2 ]
机构：
[1] Katholieke Univ Leuven, Dept Oncol, Univ Hosp Leuven, Dept Surg Oncol, Leuven, Belgium
[2] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 148卷
关键词：
D O I：
10.1016/j.ejca.2021.01.048
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：92 / 94
页数：3
相关论文
共 50 条
  • [41] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge Reply
    Dolladille, Charles
    Da-Silva, Angelique
    Alexandre, Joachim
    JAMA ONCOLOGY, 2020, 6 (11) : 1814 - 1815
  • [42] External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
    Glehr, Gunther
    Riquelme, Paloma
    Yang Zhou, Jordi
    Cordero, Laura
    Schilling, Hannah-Lou
    Kapinsky, Michael
    Schlitt, Hans J.
    Geissler, Edward K.
    Burkhardt, Ralph
    Schmidt, Barbara
    Haferkamp, Sebastian
    Hutchinson, James A.
    Kronenberg, Katharina
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Incidence of immune-related adverse events with pembrolizumab in advanced melanoma and correlation with treatment response: A single institution review of irAEs.
    Myrdal, Caitlyn N.
    Mehta, Paras
    Smith, Eric
    Briones, Kimberly
    Albright, Jason
    Curiel-Lewandrowski, Clara
    McBride, Ali
    Sundararajan, Srinath
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
    Dolladille, Charles
    Ederhy, Stephane
    Sassier, Marion
    Cautela, Jennifer
    Thuny, Franck
    Cohen, Ariel A.
    Fedrizzi, Sophie
    Chretien, Basile
    Da-Silva, Angelique
    Plane, Anne-Flore
    Legallois, Damien
    Milliez, Paul U.
    Lelong-Boulouard, Veronique
    Alexandre, Joachim
    JAMA ONCOLOGY, 2020, 6 (06) : 865 - 871
  • [45] Immune-Related Adverse Events From Immune Checkpoint Inhibitors
    Marrone, K. A.
    Ying, W.
    Naidoo, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 242 - 251
  • [46] Immune-related adverse events of immune checkpoint inhibitors: a review
    Yin, Qinan
    Wu, Liuyun
    Han, Lizhu
    Zheng, Xingyue
    Tong, Rongsheng
    Li, Lian
    Bai, Lan
    Bian, Yuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Renal immune-related adverse events of immune checkpoint inhibitor
    Hu, Rongrong
    Chen, Minjiang
    Xu, Yan
    Wang, Mengzhao
    Zheng, Ke
    Li, Xuemei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (06) : 305 - 311
  • [48] Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
    Postow, Michael A.
    Sidlow, Robert
    Hellmann, Matthew D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 158 - 168
  • [49] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Daphne Day
    Aaron R. Hansen
    BioDrugs, 2016, 30 : 571 - 584
  • [50] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
12345